NuGen Medical Devices Inc (TSE:NGMD) has released an update.
NuGen Medical Devices Inc. has released its Q1 2024 financial results, which align with management’s expectations and reflect strides in smaller markets ahead of a Q2 ramp-up with new distribution partners in major markets. The company has strengthened its financial position by renegotiating long-term debt, and under new leadership, is focusing on commercializing its needle-free InsuJet device, with increased efforts in patient awareness, distribution execution, and clinical community education.
For further insights into TSE:NGMD stock, check out TipRanks’ Stock Analysis page.
